WallStSmart

Dollar Tree Inc (DLTR)vsYoulife Group Inc. American Depositary Shares (YOUL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dollar Tree Inc generates 947% more annual revenue ($19.41B vs $1.85B). DLTR leads profitability with a 6.6% profit margin vs 2.3%. YOUL trades at a lower P/E of 9.4x. DLTR earns a higher WallStSmart Score of 70/100 (B-).

DLTR

Strong Buy

70

out of 100

Grade: B-

Growth: 6.0Profit: 6.5Value: 8.0Quality: 5.0
Piotroski: 6/9Altman Z: 1.82

YOUL

Hold

50

out of 100

Grade: D+

Growth: 9.3Profit: 3.5Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DLTRUndervalued (+26.1%)

Margin of Safety

+26.1%

Fair Value

$169.12

Current Price

$96.51

$72.61 discount

UndervaluedFair: $169.12Overvalued

Intrinsic value data unavailable for YOUL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DLTR3 strengths · Avg: 8.7/10
Return on EquityProfitability
31.7%10/10

Every $100 of equity generates 32 in profit

PEG RatioValuation
0.968/10

Growing faster than its price suggests

P/E RatioValuation
15.9x8/10

Attractively priced relative to earnings

YOUL3 strengths · Avg: 9.3/10
P/E RatioValuation
9.4x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
5300.0%10/10

Earnings expanding 5300.0% YoY

Revenue GrowthGrowth
17.7%8/10

17.7% revenue growth

Areas to Watch

DLTR3 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

Profit MarginProfitability
6.6%3/10

6.6% margin — thin

Debt/EquityHealth
1.513/10

Elevated debt levels

YOUL4 concerns · Avg: 2.5/10
Market CapQuality
$64.64M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.4%3/10

ROE of 6.4% — below average capital efficiency

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Operating MarginProfitability
-4.2%1/10

Operating margin of -4.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : DLTR

The strongest argument for DLTR centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.96 suggests the stock is reasonably priced for its growth.

Bull Case : YOUL

The strongest argument for YOUL centers on P/E Ratio, EPS Growth, Revenue Growth. Revenue growth of 17.7% demonstrates continued momentum.

Bear Case : DLTR

The primary concerns for DLTR are Altman Z-Score, Profit Margin, Debt/Equity. Debt-to-equity of 1.51 is elevated, increasing financial risk.

Bear Case : YOUL

The primary concerns for YOUL are Market Cap, Return on Equity, Profit Margin. Thin 2.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

DLTR profiles as a value stock while YOUL is a growth play — different risk/reward profiles.

YOUL is growing revenue faster at 17.7% — sustainability is the question.

DLTR generates stronger free cash flow (970M), providing more financial flexibility.

Monitor DISCOUNT STORES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DLTR scores higher overall (70/100 vs 50/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dollar Tree Inc

CONSUMER DEFENSIVE · DISCOUNT STORES · USA

Dollar Tree is an American chain of discount variety stores that sells items for $1 or less, headquartered in Chesapeake, Virginia.

Visit Website →

Youlife Group Inc. American Depositary Shares

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Youlife Group Inc. (Ticker: YOUL) stands at the forefront of the global health and wellness sector, offering cutting-edge lifestyle products and tailored health solutions aimed at improving quality of life. The company's emphasis on sustainability and community engagement aligns effectively with the rising demand for wellness and preventative care, presenting a compelling market opportunity. With robust strategic partnerships and a steadfast focus on research and development, Youlife is well-positioned to leverage growth opportunities and generate substantial value for institutional investors navigating the evolving health landscape.

Want to dig deeper into these stocks?